|
|
 |
|
Viewing report
|
|
|
|
Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Global Markets Direct, Nov 2008, Pages: 55
1 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
3 Definitions of Markets Covered in the Report 9
3.1 lrug delivery devices 9
3.2 Inhalation Systems 9
3.2.1 Metered Dose Inhaler 9
3.2.2 Dry powder inhaler 9
3.3 Infusion Systems 9
3.3.1 Infusion pumps 9
3.3.2 Syringe pumps 9
3.3.3 Disposable Infusion sets 10
4 Healthcare Sector Review 11
5 Regulation System 12
5.1 Device Classification 12
5.2 Registration Process 12
5.3 Labeling Requirements 14
5.4 Import Documentation 15
6 Pricing and Reimbursement 16
7 Distribution Structure 17
8 Drug Delivery Devices In Mexico 18
8.1 Drug Delivery Devices Cross Country Comparison (2000-2012) 18
8.2 Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
8.3 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2012 23
8.4 Drug Delivery Devices, Mexico Company share (2006-2007) 26
9 Infusion Systems In Mexico 27
9.1 Infusion Systems Overall Revenue (2000-2012) 27
9.2 Infusion Systems Overall Volume (2000-2012) 29
9.3 Infusion Systems Average Price (2000-2012) 30
9.4 Infusion Systems Distribution Share (2006-2007) 30
9.5 Infusion Systems, Mexico, Company Share (2006-2007) 31
10 Inhalation Systems In Mexico 32
10.1 Inhalation Systems Overall Revenue (2000-2012) 32
10.2 Inhalation Systems Overall Volume (2000-2012) 34
10.3 Inhalation Systems Average Price (2000-2012) 36
10.4 Inhalation Systems Distribution Share (2006-2007) 36
10.5 Inhalation Systems, Mexico, Company Share (2006-2007) 37
11 3M Company Company Profile 38
11.1 Company Overview 38
11.2 Value Chain Analysis 39
11.2.1 Manufacturing 39
11.2.2 Product Development 39
11.2.3 Sales and Marketing 40
12 AstraZeneca PLC Company Profile 41
12.1 Company Overview 41
13 Baxter International Inc. Company Profile 42
13.1 Company Overview 42
13.2 Value Chain Analysis 43
13.2.1 Manufacturing 43
13.2.2 Product Development 43
13.2.3 Sales and Marketing 44
14 Boehringer Ingelheim GmbH Company Profile 45
14.1 Company Overview 45
14.2 Value Chain Analysis 46
14.2.1 Manufacturing 46
14.2.2 Product Development 47
14.2.3 Sales and Marketing 47
15 GlaxoSmithKline plc Company Profile 48
15.1 Company Overview 48
16 Novartis Medical Nutrition Company Profile 49
16.1 Company Overview 49
17 Appendix 50
17.1 Global Markets Direct Research Methodology 50
17.2 Coverage 51
17.3 Secondary Research 51
17.4 Primary Research 52
17.5 Models 52
17.6 Forecasts 53
17.7 Expert Panels 53
17.8 Currency Conversion 54
17.9 Contact Us 55
17.10 Disclaimer 55
Executive Summary
1.2 List of Figures
Figure 1: Drug Delivery Devices Cross Country Comparison (2000-2012) 18
Figure 2: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Drug Delivery Devices, Mexico, Portfolio Analysis, 2000-2012 20
Figure 4: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 21
Figure 5: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 22
Figure 6: Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2012 23
Figure 7: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2007 24
Figure 8: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2007-2012 25
Figure 9: Drug Delivery Devices, Mexico Company share (%), 2007 26
Figure 10: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 27
Figure 11: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 28
Figure 12: Infusion Systems, Mexico, Company Share (%), 2007 31
Figure 13: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 32
Figure 14: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 33
Figure 15: Inhalation Systems, Mexico, Overall Volume (Units), Historic, 2000-2007 34
Figure 16: Inhalation Systems, Mexico, Overall Volume (Units), Forecast, 2007-2012 35
Figure 17: Inhalation Systems, Mexico, Company Share (%), 2007 37
Figure 18: 3M Healthcare Value Chain Analysis 39
Figure 19: Baxter International Inc. Value Chain Analysis 43
Figure 20: Boehringer Ingelheim GmbH Value Chain Analysis 46
Figure 21: Global Markets Direct Methodology 50
Customers who bought this item also bought
Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
European Insulin Delivery Devices Market
Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015
South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
US Insulin Delivery Devices: Patient Acceptance Drives Demand
Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
|
|
|
|
